# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-017951
Filing Date
2023-05-12
Accepted
2023-05-12 17:02:10
Documents
62
Period of Report
2023-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | cpix-20230331.htm iXBRL | 10-Q | 803834
2 | EX-10.1 | ajkazimiemploymentagreemen.htm | EX-10.1 | 37287
3 | EX-10.2 | jameshermanemploymentagree.htm | EX-10.2 | 34504
4 | EX-10.3 | toddanthony-employmentagre.htm | EX-10.3 | 34401
5 | EX-10.4 | chrisbittermanemploymentag.htm | EX-10.4 | 34414
6 | EX-10.5 | johnhammemploymentagreemen.htm | EX-10.5 | 34345
7 | EX-31.1 | a2023q1-exhibit311.htm | EX-31.1 | 12647
8 | EX-31.2 | a2023q1-exhibit312.htm | EX-31.2 | 12641
9 | EX-32.1 | a2023q1-exhibit321.htm | EX-32.1 | 6972
15 |  | image_0.jpg | GRAPHIC | 39614
| Complete submission text file | 0001628280-23-017951.txt |  | 4331969

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | cpix-20230331.xsd | EX-101.SCH | 32432
11 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | cpix-20230331_cal.xml | EX-101.CAL | 51005
12 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | cpix-20230331_def.xml | EX-101.DEF | 125127
13 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | cpix-20230331_lab.xml | EX-101.LAB | 386484
14 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | cpix-20230331_pre.xml | EX-101.PRE | 251786
56 | EXTRACTED XBRL INSTANCE DOCUMENT | cpix-20230331_htm.xml | XML | 491931

Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33637 | Film No.: 23916855
SIC: 2834 Pharmaceutical Preparations